-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Emergency Medicine, Latest HeadlinesTweet
-
Mashup Score: 3Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab - 1 year(s) ago
Immune checkpoint inhibitors have revolutionised cancer treatment by offering durable responses to many patients with solid and haematological cancers. The high prices and increasing use of immune checkpoint inhibitors put considerable strain on health-care budgets globally. This financial strain could jeopardise patients’ access to these anti-cancer therapies. However, substantial evidence…
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New Personal View: Alternative #dosing strategies for #immunecheckpointinhibitors to improve #costeffectiveness: a special focus on #nivolumab and #pembrolizumab https://t.co/miiCbK3sun
-
-
Mashup Score: 0Lack of Harmonized Adherence Criteria in Allergen Immunotherapy Prevents Comparison of Dosing and Application Strategies: A Scoping Review - 2 year(s) ago
Allergen immunotherapy (AIT) involves the application of increasing doses of allergen extract (as oral, sublingual, or subcutaneous immunotherapy) until immunologic tolerance is reached. Successful AIT relies on the consistent administration of allergen extract; therefore, adherence to these treatments is vital for compelling long-term results.Our review discusses the current terminology from…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! Lack of Harmonized Adherence Criteria in #Allergen #Immunotherapy #Prevents #Comparison of #Dosing and #Application #Strategies: A Scoping Review https://t.co/qAOai18Etz
-
-
Mashup Score: 1
Zandelisib 60 mg once daily on an intermittent dosing schedule was safe, with low frequency of grade 3 or worse adverse events, warranting the ongoing global phase 2 and phase 3 trials.
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ICYMI: #Zandelisib with continuous/intermittent #dosing as monotherapy or in combination with #rituximab in patients with R/R #Bcell malignancy: a multicentre, first-in-patient, phase 1b trial #leusm #lymsm https://t.co/x6z9Nyj0ER
-
-
Mashup Score: 0Reply to “House dust mite liquid SLIT effective in atopic dermatitis, even with suboptimal dosing” - 2 year(s) ago
We appreciated the comments of Larenas-Linnemann and Pech1 on our recent article.2 Their concerns regarding sublingual immunotherapy (SLIT) schedule, optimal dose, and composition of allergenic extracts are fundamental to our specialty. However, Larenas-Linnemann and Pech’s analysis was based on studies conducted in patients with rhinitis and/or asthma, or on experimental data from a mouse model…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! Reply to “ #House #dust #mite #liquid #SLIT effective in #atopic #dermatitis, even with #suboptimal #dosing” https://t.co/dinPZWWxdR
-
-
Mashup Score: 0House dust mite liquid SLIT effective in atopic dermatitis even with suboptimal dosing - 2 year(s) ago
We have read the article by Langer et al1 on sublingual immunotherapy (SLIT) with a house dust mite (HDM) extract for atopic dermatitis (AD) with great interest and would like to congratulate our Brazilian colleagues for having been able to conduct a double-blind, placebo-controlled trial under the not always favorable local circumstances and with budget limitations. The study is of even greater…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! #House #dust #mite #liquid #SLIT effective in #atopic #dermatitis even with #suboptimal #dosing https://t.co/QQw1NINkuO
-
-
Mashup Score: 2
Obesity is highly prevalent in hospitalized patients admitted with COVID-19. Evidence based guidelines are available for COVID-19-related therapies but dosing information specific to patients with obesity is lacking. Failure to account for the pharmacokinetic alterations that exist in this population can lead to underdosing, and treatment failure, or overdosing, resulting in an adverse effect….
Source: BioMed CentralCategories: Critical Care, Latest HeadlinesTweet-
#CritCare #OpenAccess #COVID_19: guidance for making treatment #dosing decisions in obese patients https://t.co/7lgHbg072b @jlvincen @ISICEM #FOAMed #FOAMcc #BMC #ICU #Dexamethasone #Baricitinib #Tofacitinib #Tocilizumab #Sarilumab #Remdesivir https://t.co/VM5VgQOcCY
-
-
Mashup Score: 5Most Oncologists Discuss Drug Side Effects, Open to Reduce Doses - 2 year(s) ago
All oncologists surveyed indicated that they ask patients with metastatic breast cancer about side effects at every visit, and the vast majority are open to flexible dosing.
Source: MedscapeCategories: Latest Headlines, Oncologists2Tweet-
The authors concluded: "these patient-centered dosing discussions should be part of routine care and may consequently improve [quality of life] for patients with MBC. (excellent that @Medscape elected to cover this poster!) https://t.co/OFY2vKQmaP? #SABCS21 #CancerCare #dosing
-
-
Mashup Score: 1Vaccine Dosing & Schedule - 3 year(s) ago
Last Reviewed: October 25, 2021 On this page: Overview Additional Doses Primary Series Immunocompetent Populations Immunocompromised Populations Booster Doses Mixed Products Timing/Intervals Coadministration Resources Multimedia The following is a curated review of key information and literature about this topic. It is not comprehensive of all data related to this…
Source: www.idsociety.orgCategories: Geriatrics, Latest HeadlinesTweet-
RT @RealTimeCOVID19: Check out the #RealTimeCOVID19 #vaccine #dosing & schedule page https://t.co/vn32QpMs6P @IDSAInfo @SHEA_Epi @SIDPha…
-
-
Mashup Score: 1
Removing race from the CKD-EPI equation will calculate a lower eGFR for Black patients and exclude more patients from receiving anticancer therapy, which could lead to undertreatment of Black patients with cancer and adversely affect their outcomes.
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ICYMI: Effect of removing #race from glomerular filtration rate-estimating equations on #anticancer #drug #dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participants https://t.co/YTvNwQsOE7
-
Dosing inconsistencies plagued #pediatric #acetaminophen for years. Sherry Yafai, MD, says #EPs are now seeing the same problems with #Cannabis, as inconsistent #dosing contributes to #overdoses. https://t.co/4xnijYHIgD https://t.co/yc1fnBnQkP